Achieving Remission with Methotrexate or TNFi Linked to Lower CV Risk in Rheumatoid Arthritis
May 31st 2023An analysis of patient data from Sweden and Norway detail the impact of achieving remission with methotrexate or TNF inhibitors on risk of acute coronary syndrome in patients with rheumatoid arthritis.
BE VITAL: Bimekizumab Helps Control, Attenuate Disease Activity in Psoriatic Arthritis
May 31st 2023Data from the BE VITAL OLE study, which included patients from the BE COMPLETE and BE OPTIMAL studies, suggests the benefits of bimekizumab in patients with psoriatic arthritis with inadequate response or intolerance to TNF inhibitors were sustained for up to 52 weeis.
Improve Shared Decision Making Between Providers and Patients with Rheumatic Disease
June 1st 2022Research presented at EULAR aims to enhance communication with a conversation aid so patients can address challenges they encounter as a result of rheumatic and musculoskeletal disease with a rheumatologist.